Skip to main content
Watch Insiders
HEPA filings

Corporate insider profile

Gary S. Stetz Filing Activity

Latest reported as Interim CEO of Hepion Pharmaceuticals, Inc. (HEPA).

Purchase filings
2
Reported companies
2
Net open-market value
-$193,882.81
Latest transaction
Aug 3, 2026

Affiliated corporations

Reported company relationships

HEPALatest reported

Hepion Pharmaceuticals, Inc.

Interim CEO

CNTNPrior filing

Canton Strategic Holdings, Inc.

Corporate insider

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 3, 2026Hepion Pharmaceuticals, Inc. (HEPA)Interim CEOOpen Market Purchase2,000,000$0.05$100,000
May 26, 2026Canton Strategic Holdings, Inc. (CNTN)Corporate insiderSale100,351$3.43$343,883
Apr 21, 2026Hepion Pharmaceuticals, Inc. (HEPA)Interim CEOOpen Market Purchase1,250,000$0.04$50,000